97125 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN
#2ANTI-PCRV AND PSL BISPECIFIC ANTIBODIES FOR TREATMENT OF BRONCHIECTASIS
#3COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES
#4PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION
#5VHH ANTIBODY
#6DIMERIC PROTEIN COMPLEXES AND USES THEREOF
#7ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#8MONOCLONAL ANTIBODIES TO PROTECT AGAINST GRAM-NEGATIVE PATHOGENS
#9Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosa
#10COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN
#11MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA
#12AN ANTIBODY FRAGMENT BASED ANTIMICROBIAL CONJUGATE SELECTIVELY TARGETING PSEUDOMONAS
#13Vaccines targeting Pseudomonas aeruginosa
#14METHOD AND KIT FOR DETECTING PRESENCE AND/OR AMOUNT OF BACTERIA IN FOOD/DRINK SAMPLE, ENVIRONMENTAL SAMPLE, OR BIOLOGICAL SAMPLE
#15Combinations of Antibodies and Bispecific Antibodies Comprising Antigen-Binding Specifically Recognizing Pseudomonas PcrV and Psl
#16ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF
#17Antibodies Specifically Recognizing Pseudomonas Psl and Uses Thereof
#18PROTEIN MOLECULE USEFUL FOR ANTI-PSEUDOMONAS AERUGINOSA VACCINE
#19IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA
#20Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
#21CD40-L BLOCKADE TO ENHANCE SYNTHETIC ANTIBODY THERAPY
#22ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES THEREOF
#23MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF
#24ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF
#25ANTIBODY AGAINST THE OPRF PROTEIN OF PSEUDOMONAS AERUGINOSA, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
#26Binding moieties for biofilm remediation
#27COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES
#28Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)
#29COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN
#30Proteins and nucleic acids useful in vaccines targeting
#31METHOD FOR PREVENTING OR TREATING NOSOCOMIAL PNEUMONIA
#32Antibody molecule-drug conjugates and uses thereof
#33COMPOSITIONS AND METHODS AGAINST P. AERUGINOSA INFECTIONS
#34ANTI-PSEUDOMONAS PSL BINDING MOLECULES AND USES THEREOF
#35Compositions and methods for inhibiting pathogen infection
#36MODIFIED PSEUDOMONAS EXOTOXIN A
#37Immunogenic Composition
#38Anti-PcrV antibodies that bind PcrV, compositions comprising anti-PcrV antibodies, and methods of use thereof
#39BINDING MOLECULES TARGETING PATHOGENS
#40Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas perv
#41Methods for predicting the risk of developing pulmonary colonization/infection by
#42METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM
#43Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)
#44Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#45Live attenuated vaccines
#46PSEUDOMONAS AERUGINOSA PCRV BINDING SINGLE VARIABLE DOMAIN ANTIBODIES
#47Binding moieties for biofilm remediation
#48MODIFIED PSEUDOMONAS EXOTOXIN A
#49Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
#50Type III secretion system targeting molecules
#51Vaccines targeting
#52Anti-Psl binding molecules and uses thereof
#53DNA Antibody Constructs for Use against Pseudomonas Aeuruginosa
#54Gonorrheal MtrE peptides and vaccines
#55PcrV binding single variable domain antibodies
#56Binding moieties for biofilm remediation
#57Compositions and methods for inhibiting pathogen infection
#58Method for preventing or treating nosocomial pneumonia
#59Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
#60BINDING MOLECULES TARGETING PATHOGENS
#61BACTERIOPHAGE-CONTAINING THERAPEUTIC AGENTS
#62Insecticidal proteins and methods for their use
#63Pseudomonas exotoxin A with less immunogenic B cell epitopes
#64MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOF
#65Treatment of polybacterial infections
#66Antibody molecule-drug conjugates and uses thereof
#67Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#68Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#69Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
#70NOVEL OPRF/I FUSION PROTEINS, THEIR PREPARATION AND USE
#71Acinetobacter baumannii antigens and the uses thereof
#72Type III secretion system targeting molecules
#73Anti-LPS O11 antibody
#74Anti-pseudomonas Psl binding molecules and uses thereof
#75Polypeptdes, cells, and methods for biofilm therapy and detection
#76Binding moieties for biofilm remediation
#77Live attenuated vaccines
#78Methods of Improving the Therapeutic Efficacy and Utility of Antibody Fragments
#79SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE
#80Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof
#81Antibody therapeutics that bind OprF
#82exotoxin A with less immunogenic B cell epitopes
#83Flagellin fusion proteins and use thereof to induce immune responses against
#84BINDING MOIETIES FOR BIOFILM REMEDIATION
#85Gonorrheal MtrE peptides and vaccines
#86COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES
#87BINDING MOIETIES FOR BIOFILM REMEDIATION
#88BINDING MOLECULES TARGETING PATHOGENS
#89Human antibodies against LPS derived from transgenic xenomouse
#90Compositions and Methods for the Removal of Biofilms
#91Synthetic Oligosaccharides for P. Aeruginosa Vaccine
#92Modified exotoxin A
#93BINDING MOIETIES FOR BIOFILM REMEDIATION
#94Pseudomonas aeruginosa PCRV binding single variable domain antibodies
#95ANTIBODIES TO THE PCRV ANTIGEN OF PSEUDOMONAS AERUGINOSA
#96Combination therapies using anti-pseudomonas PSL and PCRV binding molecules
#97PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS
#98Multispecific and multivalent binding proteins and uses thereof
#99Peptide or arrangement of peptides forming a epitope binding site
#100Anti-pseudomonas Psl binding molecules and uses thereof
#101exotoxin A with less immunogenic B cell epitopes
#102OprF/I fusion proteins, their preparation and use
#103Compositions against bacterial toxins
#104Insecticidal proteins and methods for their use
#105Antibodies and immunotoxins that target human glycoprotein NMB
#106Bacteriophage-containing therapeutic agents
#107Human antibodies against LPS
#108Humanized PcrV antibody having anti-pseudomonal activity
#109Therapeutic antibodies against flagellated
#110Methods for the Treatment of an Infectious Bacterial Disease with an Anti-Lactone or Lactone Derived Signal Molecules Antibody
#111ANTIBODY AGAINST SEROTYPE G LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#112Method of diagnosing and treating melioidosis
#113ANTIBODY AGAINST SEROTYPE B LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#114ANTIBODY AGAINST SEROTYPE I LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#115Methods For Inducing Autolysis In Infectious Bacteria
#116ANTIBODY AGAINST SEROTYPE A LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#117ANTIBODY AGAINST SEROTYPE E LIPOPOLYSACCHARIDE OF PSEUDOMONAS AERUGINOSA
#118IMMUNOGENIC COMPOSITION COMPRISING S. PNEUMONIAE POLYSACCHARIDES CONJUGATED TO CARRIER PROTEINS
#119Secretion of antibodies without signal peptides from bacteria
#120Antibodies and immunotoxins that target human glycoprotein NMB
#121Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa
#122Bacteriophage-containing therapeutic agents
#123HUMANIZED PCRV ANTIBODY HAVING ANTI-PSEUDOMONAL ACTIVITY
#124Flagellin fusion proteins and use thereof to induce immune responses against
#125METHODS OF IMPROVING THE THERAPEUTIC EFFICACY AND UTILITY OF ANTIBODY FRAGMENTS
#126Antibodies to the PcrV antigen of
#127IMMUNOTOXINS AND USES THEREOF
#128Compositions and methods for the removal of biofilms
#129Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor
#130Human anti-It-2 antibodies derived from transgenic xenomouse
#131Method of treating a staphylococcus infection in a patient having a low-level pathogenic infection
#132Identification of a conserved inner core oligosaccharide of lipopolysaccharide as a vaccine antigen
#133Antibody against PcrV
#134Methods For Inducing Autolysis In Infectious Bacteria
#135Bacteriophage-containing therapeutic agents
#136PSEUDOMONAS AERUGINOSA-OUTER MEMBRANE PROTEIN PA4710
#137Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
#138PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
#139TYPE III SECRETION SYSTEM COMPONENT PROTEIN PA1698 OF PSEUDOMONAS AERUGINOSA
#140COMBINATION ANTIBIOTIC AND ANTIBODY THERAPY FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION
#141AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AND METHODS OF MAKING AND USING THEM
#142outer membrane protein-106 polypeptide, gene sequence and uses thereof
#143Antibodies and immunotoxins that target human glycoprotein NMB
#144Method or agent for inhibiting the function of efflux pump
#145Novel Methods of Diagnosis of Treatment of P. Aeruginosa Infection and Reagents Therefor
#146Antibodies against flagellin and uses thereof
#147Method and compositions for immunization with the V antigen
#148Antibodies against flagellin and uses thereof
#149Antibodies to the PcrV antigen of
#150Pseudomonas Aeruginosa Outer Membrane Protein PA5158
#151outer membrane protein PA0427
#152Methods For Reducing Biofilm Formation In Infectious Bacteria
#153Human monoclonal antibody specific for lipopolysaccharides (LPS) of the IATS O11 serotype
#154protein, nucleic acid sequence and uses thereof
#155Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse
#156MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
#157Modified plant viruses and methods of use thereof
#158Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
#159Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule
#160Methods For Inducing Autolysis In Infectious Bacteria
#161Bacteriophage-containing therapeutic agents
#162outer membrane protein-106 polypeptide, gene sequence and uses thereof
#163Secretion of antibodies without signal peptides from bacteria
#164P. aeruginosa mucoid exopolysaccharide specific binding peptides
#165Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
#166mucoid exopolysaccharide specific binding peptides
#167Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of
#168Methods and compositions relating to mannuronic acid specific binding peptides
#169Antibody specificity transfer using minimal essential binding determinants
#170Heteropolymer complexes and methods for their use
#171Method and kit for identifying pseudomonas aeruginosa
#172Polypeptides of ()
#173Method and compositions for immunization with the V antigen